Brian Lloyd Acquires 2,000 Shares of Merit Medical Systems (NASDAQ:MMSI) Stock

Merit Medical Systems, Inc. (NASDAQ:MMSI) insider Brian Lloyd bought 2,000 shares of the stock in a transaction dated Thursday, May 7th. The shares were purchased at an average price of $62.62 per share, with a total value of $125,240.00. Following the completion of the transaction, the insider directly owned 2,000 shares in the company, valued at approximately $125,240. The trade was a ? increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Merit Medical Systems Trading Up 1.4%

Shares of MMSI opened at $61.15 on Wednesday. The company’s fifty day moving average is $68.41 and its 200 day moving average is $78.88. Merit Medical Systems, Inc. has a fifty-two week low of $59.74 and a fifty-two week high of $100.05. The stock has a market capitalization of $3.65 billion, a PE ratio of 26.47, a P/E/G ratio of 1.88 and a beta of 0.58. The company has a debt-to-equity ratio of 0.45, a quick ratio of 3.46 and a current ratio of 5.08.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings results on Thursday, April 30th. The medical instruments supplier reported $0.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.84 by $0.10. Merit Medical Systems had a net margin of 9.03% and a return on equity of 13.54%. The company had revenue of $381.88 million for the quarter, compared to the consensus estimate of $377.59 million. During the same quarter in the prior year, the firm earned $0.86 earnings per share. Merit Medical Systems’s revenue was up 7.4% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Sell-side analysts expect that Merit Medical Systems, Inc. will post 3.61 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

MMSI has been the subject of several recent research reports. Compass Point set a $107.00 price target on Merit Medical Systems in a research report on Monday, April 20th. Piper Sandler decreased their price objective on Merit Medical Systems from $106.00 to $96.00 and set an “overweight” rating on the stock in a research report on Friday, April 17th. Barrington Research lowered their price objective on Merit Medical Systems from $109.00 to $107.00 and set an “outperform” rating for the company in a research note on Monday, April 20th. Canaccord Genuity Group dropped their target price on Merit Medical Systems from $90.00 to $85.00 and set a “buy” rating for the company in a report on Friday, May 1st. Finally, Needham & Company LLC decreased their price target on Merit Medical Systems from $101.00 to $90.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Eight equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $92.80.

Hedge Funds Weigh In On Merit Medical Systems

Several hedge funds have recently bought and sold shares of the business. Los Angeles Capital Management LLC purchased a new stake in Merit Medical Systems in the fourth quarter worth $25,000. Maseco LLP purchased a new stake in shares of Merit Medical Systems during the fourth quarter valued at $26,000. Torren Management LLC bought a new position in shares of Merit Medical Systems in the fourth quarter worth about $38,000. Covestor Ltd grew its holdings in shares of Merit Medical Systems by 252.6% in the fourth quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier’s stock worth $41,000 after purchasing an additional 336 shares during the last quarter. Finally, Danske Bank A S purchased a new position in Merit Medical Systems in the 3rd quarter worth about $42,000. Institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.